If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Mycobacterium tuberculosis Medicine & Life Sciences
Tuberculosis Medicine & Life Sciences
Rifampin Medicine & Life Sciences
Isoniazid Medicine & Life Sciences
Mutation Medicine & Life Sciences
Multidrug-Resistant Tuberculosis Medicine & Life Sciences
Ethambutol Medicine & Life Sciences
Sputum Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2009 2021

Biomarkers
Tuberculosis
Therapeutics
Pharmacokinetics
Genome
Cell Wall
Pharmaceutical Preparations
DNA Gyrase
Mycobacterium tuberculosis
Respiration
Rifampin
Tuberculosis
Pharmaceutical Preparations
Multidrug-Resistant Tuberculosis
Fluoroquinolones
Vulnerable Populations
Mycobacterium tuberculosis
Cell Wall
Pharmaceutical Preparations
Respiration
Mycobacterium tuberculosis
Cell Wall
Pharmaceutical Preparations
Respiration
bedaquiline

Research Output 1992 2019

Lack of association of novel mutation Asp397Gly in aftB gene with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis

Giri, A., Safi, H., Cabibbe, A. M., Gupta, S., Narang, A., Tyagi, G., Shrivastava, K., Kumar, C., Kumar Sharma, N., Lingaraju, S., Trovato, A., Battaglia, S., Cirillo, D. M., Bose, M., Alland, D. & Varma-Basil, M., Mar 1 2019, In : Tuberculosis. 115, p. 49-55 7 p.

Research output: Contribution to journalArticle

Ethambutol
Mycobacterium tuberculosis
Mutation
Genes
Microbial Sensitivity Tests

Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent

Gallardo-Macias, R., Kumar, P., Jaskowski, M., Richmann, T., Shrestha, R., Russo, R., Singleton, E., Zimmerman, M. D., Ho, H. P., Dartois, V., Connell, N., Alland, D. & Freundlich, J., Feb 15 2019, In : Bioorganic and Medicinal Chemistry Letters. 29, 4, p. 601-606 6 p.

Research output: Contribution to journalArticle

Nitrofurans
Antitubercular Agents
Cytotoxicity
Vero Cells
Pharmacokinetics

The authors reply

Colangeli, R., Kim, S. & Alland, D., Jan 10 2019, In : New England Journal of Medicine. 380, 2, p. 197-198 2 p.

Research output: Contribution to journalLetter

Transmission phenotype of Mycobacterium tuberculosis strains is mechanistically linked to induction of distinct pulmonary pathology

Verma, S., Bhatt, K., Lovey, A., Ribeiro-Rodrigues, R., Durbin, J., Jones-López, E. C., Palaci, M., Vinhas, S. A., Alland, D., Dietze, R., Ellner, J. J. & Salgame, P., Mar 1 2019, In : PLoS pathogens. 15, 3, p. e1007613

Research output: Contribution to journalArticle

Open Access
Mycobacterium tuberculosis
Pathology
Phenotype
Lung
Macrophages
4 Citations (Scopus)

Bacterial factors that predict relapse after tuberculosis therapy

Colangeli, R., Jedrey, H., Kim, S., Connell, R., Ma, S., Venkata, U. D. C., Chakravorty, S., Gupta, A., Sizemore, E. E., Diem, L., Sherman, D. R., Okwera, A., Dietze, R., Boom, W. H., Johnson, J. L., Kenzie, W. R. M. & Alland, D., Aug 30 2018, In : New England Journal of Medicine. 379, 9, p. 823-833 11 p.

Research output: Contribution to journalArticle

Microbial Sensitivity Tests
Tuberculosis
Recurrence
Isoniazid
Rifampin